GenprexOffering
Completed S-1 IPO NASDAQ: GNPX Lung Cancer Clinical Stage Gene Therapy
Completed S-1 IPO NASDAQ: GNPX Lung Cancer Clinical Stage Gene Therapy
Offering Completed - Earn an annual dividend of 8%, paid monthly. $500 minimum investment
Science Officer × Ron Zimmerman Co-Founder & Chief Science Officer Ron ... and characterization of therapeutic proteins. With offices, laboratories and production ... and bioequivalent protein products. David Wood President & Chief Executive Officer ...
Earn an annual dividend of 8%, paid monthly. $500 minimum investment
and officers; (iii) financial statements for the past two years (which do not need ...
Make an investment in IdentifySensors Biologics.
Invest in Fast-Growing Organic Agriculture Technology!
Earn an annual dividend of 8%, paid monthly. $500 minimum investment
and beverages. × Gerald (Jerry) Ellenburg Chairman and Chief Executive Officer ... Chief Marketing & Experience Officer John has 32 years in marketing, ... Operating Officer Nick is a seasoned executive with over 30 years ...
estate. Property assets will include retail, office, and condominiums. ...